Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

Nexstim announces agreement on growth financing

Af Antti SiltanenAnalytiker
Nexstim

Translation: Original comment published in Finnish on 8/11/2023 at 6:30 am EEST.

Nexstim announced on Thursday that it has agreed a EUR 1.5 million loan with Nordea. According to the press release, the loan will finance strategic investments, growth and working capital needs. The term of the loan is five years and the loan is expected to be drawn down during August. We estimate that the loan could be linked to Nexstim's clinic network investments, but in the absence of further information, we are waiting for more details for now.

Nexstim has been preparing for a long time to expand its network of clinics

In January 2022, Nexstim announced a strategic investment in a Californian clinic services company. PNC Management Services, LLC provides management, consulting, administrative and other support services to the local TMS clinic. In March 2022, the company announced the establishment of an investment company, which we understand will be tasked with making investments in similar types of clinic service companies. We estimate that the investments may also involve equipment sales. Expansion of the clinic network has been a strategic focus area for Nexstim since last year, but no new investments have been heard of since PNC Management Services. We estimate that the funding now agreed could be linked to the expansion of the clinic network, either in Europe or the US. At this stage, however, no further details on the use of the funding are available, so we await further information on the subject.

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Læs mere på virksomhedsside

Key Estimate Figures05.07.2023

202223e24e
Omsætning9,56,89,0
vækst-%48,9 %-28,2 %31,9 %
EBIT (adj.)0,8-1,1-0,1
EBIT-% (adj.)8,8 %-16,7 %-1,1 %
EPS (adj.)0,18-0,17-0,03
Udbytte0,000,000,00
Udbytte %
P/E (adj.)22,8neg.neg.
EV/EBITDA22,0neg.254,5

Forumopdateringer

Jeg husker ikke sådan en meddelelse fra Karvinen, men jeg synes, denne begrundelse er mere fornuftig end den pludselige ophør af butikkernes...
for 10 timer siden
af Tee
3
Jeg har selv gættet på, at man i slutningen af året også har kunnet fokusere på mange NBS6-opdateringer, som ikke overskrider informationsgr...
for 11 timer siden
af JJ JJ
3
Man er jo lidt spændt på, hvad der kommer derfra, når intet bliver annonceret. Man får lyst til at tilføje, men hvad nu hvis.. Den er allerede...
for 17 timer siden
af QRB Strong buy
6
Jeg så det samme lige før. Jeg er kommet til den konklusion, at ingen handler vil blive annonceret fra december. Ellers kan f.eks. Brainlabs...
for 18 timer siden
af Hannu
8
Er denne handel i Danmark overhovedet blevet annonceret? Julekalenderen er måske helt gal. Den eneste handelsmeddelelse, dette kunne matche,...
for 20 timer siden
af Kyhnykeisari
27
Vejledningen er vidtrækkende, og der er ingen øvre grænse i dette tilfælde. Det er unødvendigt at meddele det, hvis vi holder os inden for retningslin...
for 22 timer siden
af Hannu
6
At nå Inderes’ estimat kræver meget aktivt salg og også leverancer for dette år, eller alternativt kræver det, at Brainlab har solgt og Sinaptica...
for 23 timer siden
af Jatast
9
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.